Search Within

Taha Merghoub

  1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (4)
Groups
  1. Center for Hematologic Malignancies (14)
  2. Department of Medicine (14)
  3. Hematologic Malignancies Research (14)
  4. Hematologic Malignancies, Division of (14)
  5. Melanoma and Immunotherapeutics Service (14)
  6. Solid Tumor Oncology Division (14)

More Groups

People
  1. Jedd Wolchok (12)
  2. Alexander Lesokhin (10)
  3. Daniel Hirschhorn Cymerman (7)
  4. Alan Houghton (6)
  5. Francesca Avogadri (4)
  6. Gabrielle Rizzuto (3)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2020 (1)
  5. 2016 (2)
  6. 2013 (1)

More Years

Publications
  1. Blood (4)
  2. Journal of Experimental Medicine (3)
  3. Cancer Immunology Research (1)
  4. Cancer Research (1)
  5. EBioMedicine (1)
  6. Immunity (1)

More Publications

Publishers
  1. American Society of Hematology (4)
  2. Rockefeller University Press (3)
  3. American Association for Cancer Research (2)
  4. Nature Publishing Group (2)
  5. Cell Press (1)
  6. Elsevier Inc. (1)

More Publishers

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Journal Article

    Łuksza, M.; Sethna, Z. M.; Rojas, L. A.; Lihm, J.; Bravi, B.; Elhanati, Y.; Soares, K.; Amisaki, M.; Dobrin, A.; Hoyos, D.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Kinase regulation of human MHC class i molecule expression on cancer cells
    Journal Article

    Brea, E. J.; Oh, C. Y.; Manchado, E.; Budhu, S.; Gejman, R. S.; Mo, G.; Mondello, P.; Han, J. E.; Jarvis, C. A.; Ulmert, D.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Lesokhin, A.; Merghoub, T.; Wolchok, J. D.
    EBioMedicine (2016)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor sells and the efficacy of CD8+ T-cell immunotherapy
    Journal Article

    Lesokhin, A. M.; Merghoub, T.; Wolchok, J. D.
    OncoImmunology (2013)

    Fulltext@MSK | Save
  • Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
    Journal Article

    Hirschhorn-Cymerman, D.; Budhu, S.; Kitano, S.; Liu, C.; Zhao, F.; Zhong, H.; Lesokhin, A. M.; Avogadri Connors, F.; Yuan, J.; Li, Y.; more...
    Journal of Experimental Medicine (2012)

    Fulltext@MSK | Save
  • Targeting intracellular antigens using chimeric antigen receptors
    Meeting Abstract

    Maus, M. V.; Merghoub, T.; Jakka, G.; Plotkin, J.; Stewart-Jones, G.; Riviere, I.; Wolchok, J.; Renner, C.; Sadelain, M.
    Molecular Therapy (2012)

    Fulltext@MSK | Save
  • Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment
    Journal Article

    Lesokhin, A. M.; Hohl, T. M.; Kitano, S.; Cortez, C.; Hirschhorn-Cymerman, D.; Avogadri, F.; Rizzuto, G. A.; Lazarus, J. J.; Pamer, E. G.; Houghton, A. N.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save